Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Nov 08, 2018 5:51pm
142 Views
Post# 28947000

RE:Beware next week - Canopy's Q

RE:Beware next week - Canopy's QI believe that Canopy has already hinted at doing what Aurora did last quarter by throwing in something like "unrealized non-cash gains on marketable securites" in order to make their net income look better than what it otherwise would be.  With all of Aurora's strategic partnerships and investments, they managed to turn an operating loss into significant positive earnings for the last quarter.

Although Canopy could indeed drop if they stick to their historical pattern of missing on earnings, it's quite possible that some of the U.S. investors might take this opportunity to switch into Aurora if ACB is able to show substantially higher total sales revenues as compared to Canopy.  Especially now that Aurora trades on the NYSE which will now make it much easier for both the American and global investors to make this switch.

GLTA
QuickThinker wrote: Canopy's Q results are next week and I think that due to poor numbers, Canopy is going to drag cannabis stocks down in general.  Unfortunately, however Canopy moves, the other cannabis stocks move.  It sucks.  I love HEXO, Aphria, and Aurora, and Canopy drags them down among others.  I'm selling most of my positions tomorrow in preparation for the quarterly next week.  I will buy back in at the 7s and hold long.  I got stuck with some Aurora in the 12s, so that will reduce my average.  I saw PYX drop today 25% due to poor Q so no stock is immune.

I will focus on American stocks for now.  TRUL is my favorite.  Very strong numbers.

https://finance.yahoo.com/news/earnings-preview-canopy-growth-corporation-153003213.html 


Bullboard Posts